HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David Meiri Selected Research

Pain (Aches)

1/2022Sex differences in medical cannabis-related adverse effects.
1/2021Prolonged Medical Cannabis Treatment is Associated With Quality of Life Improvement and Reduction of Analgesic Medication Consumption in Chronic Pain Patients.
1/2021Specific phytocannabinoid compositions are associated with analgesic response and adverse effects in chronic pain patients treated with medical cannabis.
1/2021Medical Cannabis Use and Pain: An Experience Sampling Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David Meiri Research Topics

Disease

8Neoplasms (Cancer)
01/2023 - 03/2015
6Chronic Pain
01/2021 - 12/2020
4Pain (Aches)
01/2022 - 01/2021
2Obesity
01/2024 - 09/2023
2Weight Gain
01/2024 - 09/2023
2Squamous Cell Carcinoma of Head and Neck
04/2023 - 01/2023
2Melanoma (Melanoma, Malignant)
01/2023 - 01/2019
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 01/2019
1Leukemia
02/2024
1Fatty Liver
01/2024
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2023
1Body Weight (Weight, Body)
12/2023
1Alzheimer Disease (Alzheimer's Disease)
12/2023
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
12/2022
1Inflammation (Inflammations)
07/2022
1Autism Spectrum Disorder
01/2022
1Crohn Disease (Crohn's Disease)
11/2021
1Ulcerative Colitis
01/2021
1Cancer Pain
01/2021
1Sleep Initiation and Maintenance Disorders (Insomnia)
12/2020
1Migraine Disorders (Migraine)
06/2020
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2020
1Carcinoma (Carcinomatosis)
01/2019

Drug/Important Bio-Agent (IBA)

17Medical MarijuanaIBA
01/2024 - 01/2020
6Dronabinol (THC)FDA LinkGeneric
01/2024 - 11/2020
3CannabidiolIBA
01/2024 - 07/2022
3EndocannabinoidsIBA
01/2024 - 01/2021
2Plant ExtractsIBA
04/2023 - 01/2023
2Immune Checkpoint InhibitorsIBA
01/2023 - 01/2023
2CannabinoidsIBA
07/2022 - 01/2020
2Analgesics (Analgesic Drugs)IBA
01/2021 - 01/2021
1Long Noncoding RNAIBA
02/2024
1OilsIBA
01/2024
1Dehydroepiandrosterone (DHEA)IBA
01/2024
1LipidsIBA
01/2024
1Biomarkers (Surrogate Marker)IBA
12/2023
1Glial Fibrillary Acidic ProteinIBA
12/2023
1Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA
12/2023
1Glucose (Dextrose)FDA LinkGeneric
09/2023
1Calcium Gluconate (CBG)IBA
01/2023
1cannabigerolIBA
01/2023
1Macrophage Colony-Stimulating FactorIBA
01/2023
1CytokinesIBA
01/2023
1Opioid Analgesics (Opioids)IBA
06/2020
1Tryptamines (Triptans)IBA
06/2020
1Terpenes (Terpenoids)IBA
01/2020
1NivolumabIBA
01/2019
1Proteins (Proteins, Gene)FDA Link
03/2015
1Platinum Compounds (Compounds, Platinum)IBA
03/2015
1Monomeric GTP-Binding ProteinsIBA
03/2015
1Cisplatin (Platino)FDA LinkGeneric
03/2015

Therapy/Procedure

5Therapeutics
04/2023 - 03/2015
2Immunotherapy
04/2022 - 08/2020
1Oral Administration
09/2023